These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37843119)

  • 1. Priorities and Progress in Diagnostic Research by the Antibacterial Resistance Leadership Group.
    Hanson KE; Banerjee R; Doernberg SB; Evans SR; Komarow L; Satlin MJ; Schwager N; Simner PJ; Tillekeratne LG; Patel R;
    Clin Infect Dis; 2023 Oct; 77(Suppl 4):S314-S320. PubMed ID: 37843119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial Resistance Leadership Group 2.0: Back to Business.
    Chambers HF; Evans SR; Patel R; Cross HR; Harris AD; Doi Y; Boucher HW; van Duin D; Tsalik EL; Holland TL; Pettigrew MM; Tamma PD; Hodges KR; Souli M; Fowler VG
    Clin Infect Dis; 2021 Aug; 73(4):730-739. PubMed ID: 33588438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Priorities and Progress in Gram-negative Bacterial Infection Research by the Antibacterial Resistance Leadership Group.
    Satlin MJ; van Duin D; Tamma PD; Lodise TP; Van Tyne D; Rodvold KA; Rouphael N; Evans SR; Fowler VG; Hamasaki T; Patel R; Komarow L; Baum K; Souli M; Schwager N; Bonomo RA; Doi Y;
    Clin Infect Dis; 2023 Oct; 77(Suppl 4):S305-S313. PubMed ID: 37843118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gram-Negative Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group.
    Doi Y; Bonomo RA; Hooper DC; Kaye KS; Johnson JR; Clancy CJ; Thaden JT; Stryjewski ME; van Duin D;
    Clin Infect Dis; 2017 Mar; 64(suppl_1):S30-S35. PubMed ID: 28350901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Antibacterial Resistance Leadership Group: Scientific Advancements and Future Directions.
    Chambers HF; Cross HR; Souli M; Evans SR; Patel R; Fowler VG;
    Clin Infect Dis; 2023 Oct; 77(Suppl 4):S279-S287. PubMed ID: 37843121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gram-Positive Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group.
    Doernberg SB; Lodise TP; Thaden JT; Munita JM; Cosgrove SE; Arias CA; Boucher HW; Corey GR; Lowy FD; Murray B; Miller LG; Holland TL;
    Clin Infect Dis; 2017 Mar; 64(suppl_1):S24-S29. PubMed ID: 28350900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibacterial resistance leadership group: open for business.
    Chambers HF; Bartlett JG; Bonomo RA; Chiou C; Cosgrove SE; Cross HR; Daum RS; Downing M; Evans SR; Knisely J; Kreiswirth BN; Lautenbach E; Mickley BS; Patel R; Pettigrew MM; Rodvold KA; Spellberg B; Fowler VG
    Clin Infect Dis; 2014 Jun; 58(11):1571-6. PubMed ID: 24610430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leading Antibacterial Laboratory Research by Integrating Conventional and Innovative Approaches: The Laboratory Center of the Antibacterial Resistance Leadership Group.
    Manca C; Hill C; Hujer AM; Patel R; Evans SR; Bonomo RA; Kreiswirth BN;
    Clin Infect Dis; 2017 Mar; 64(suppl_1):S13-S17. PubMed ID: 28350898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Priorities and Progress in Gram-positive Bacterial Infection Research by the Antibacterial Resistance Leadership Group: A Narrative Review.
    Doernberg SB; Arias CA; Altman DR; Babiker A; Boucher HW; Creech CB; Cosgrove SE; Evans SR; Fowler VG; Fritz SA; Hamasaki T; Kelly BJ; Leal SM; Liu C; Lodise TP; Miller LG; Munita JM; Murray BE; Pettigrew MM; Ruffin F; Scheetz MH; Shopsin B; Tran TT; Turner NA; Williams DJ; Zaharoff S; Holland TL;
    Clin Infect Dis; 2023 Oct; 77(Suppl 4):S295-S304. PubMed ID: 37843115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Antibacterial Resistance Leadership Group: Progress Report and Work in Progress.
    Chambers HF; Cross HR; Evans SR; Kreiswirth BN; Fowler VG;
    Clin Infect Dis; 2017 Mar; 64(suppl_1):S3-S7. PubMed ID: 28350896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Stewardship in Addressing Antibacterial Resistance: Stewardship and Infection Control Committee of the Antibacterial Resistance Leadership Group.
    Anderson DJ; Jenkins TC; Evans SR; Harris AD; Weinstein RA; Tamma PD; Han JH; Banerjee R; Patel R; Zaoutis T; Lautenbach E;
    Clin Infect Dis; 2017 Mar; 64(suppl_1):S36-S40. PubMed ID: 28350902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of new polymyxin derivatives for multi-drug resistant Gram-negative infections.
    Brown P; Dawson MJ
    J Antibiot (Tokyo); 2017 Apr; 70(4):386-394. PubMed ID: 28074057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New antibacterial agents for treating infections caused by multi-drug resistant Gram-negative bacteria.
    O'Neill AJ
    Expert Opin Investig Drugs; 2008 Mar; 17(3):297-302. PubMed ID: 18321229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxazolidinone antimicrobials: a patent review (2012-2015).
    Phillips OA; Sharaf LH
    Expert Opin Ther Pat; 2016 May; 26(5):591-605. PubMed ID: 26998627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of antibiotic and antibacterial agent cross-resistance in target bacteria from homes of antibacterial product users and nonusers.
    Cole EC; Addison RM; Rubino JR; Leese KE; Dulaney PD; Newell MS; Wilkins J; Gaber DJ; Wineinger T; Criger DA
    J Appl Microbiol; 2003; 95(4):664-76. PubMed ID: 12969278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic resistance patterns of Gram-negative and Gram-positive strains isolated from inpatients with nosocomial infections in a tertiary hospital in Beijing, China from 2011 to 2014.
    Zhu X; Tong A; Wang D; Sun H; Chen L; Dong M
    J Chemother; 2017 Oct; 29(5):317-320. PubMed ID: 27347770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug-resistant gram-negative organisms: a review of recently approved antibiotics and novel pipeline agents.
    Provenzani A; Hospodar AR; Meyer AL; Leonardi Vinci D; Hwang EY; Butrus CM; Polidori P
    Int J Clin Pharm; 2020 Aug; 42(4):1016-1025. PubMed ID: 32638294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survey of the susceptibility of urinary isolates to antibacterial agents in 2003.
    Ishikawa K; Hayakawa S; Miyakawa S; Kusaka M; Shiroki R; Hoshinaga K
    J Infect Chemother; 2005 Feb; 11(1):44-7. PubMed ID: 15729488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbiologic characteristics and antibiotic resistance rates of diabetic foot infections.
    Pontes DG; Silva ITDCE; Fernandes JJ; Monteiro AFG; Gomes PHDS; Ferreira MGM; Lima FG; Correia JO; Santos NJND; Cavalcante LP
    Rev Col Bras Cir; 2020; 47():e20202471. PubMed ID: 32667581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid Identification of Bacterial Antibiotic Resistance by qPCR in Infants with Gram-Negative Septicaemia: A Proof-of-Concept Study.
    Lam HS; Chan KY; Ip M; Leung KT; Lo NW; Wong RP; Li K; Ng PC
    Neonatology; 2017; 111(2):145-152. PubMed ID: 27756063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.